News

Insulin is commonly known as the key hormone in diabetes. But even for people who don't have the disease, it can be ...
All of a sudden we were just thrown into having to learn everything imaginable the same day that he needed to start shots,” ...
A recent study published in Obstetrics and Gynecology assesses hormone therapy (HT)-induced changes in cardiovascular ...
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...
Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...
The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...
Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...
Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...
Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...
Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...
Beginning (or continuing) a weight training regimen can be a powerful tool for maintaining health during menopause.